EDWARDS LIFESCIENCES CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.43 USD | -1.80% |
|
+0.57% | +13.35% |
| 26/04 | Evercore ISI Adjusts Price Target on Edwards Lifesciences to $89 From $92 | MT |
| 26/04 | Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $83 | MT |
Chart calendar Edwards Lifesciences Corporation
d86c3e3294e47315092030b.tvQl000KjYvgVdl_TwDuUVeDjJuvCtBuI4qYq4QWHsE.wYQXtnh43biweIAuIF-oHDzs3P3jM54LTMfPmvJuJqTlp1aQDlzVuaosmA~fd77cdb394cb098b8915f6b39d01aa21
Upcoming events on Edwards Lifesciences Corporation
Past events on Edwards Lifesciences Corporation
| 26/04/2024 02:30 am | Q1 2024 Earnings Call |
| 26/04/2024 01:45 am | Q1 2024 Earnings Release |
| 05/03/2024 09:00 pm | TD Cowen Health Care Conference |
| 07/02/2024 03:30 am | Q4 2023 Earnings Call |
| 07/02/2024 02:45 am | Q4 2023 Earnings Release |
| 10/01/2024 12:45 am | JPMorgan Healthcare Conference |
| 07/12/2023 10:00 pm | Investor Conference |
| 27/10/2023 03:00 am | Analyst & Investor Meeting - TMTT Q&A Session at TCT |
| 26/10/2023 | Transcatheter Cardiovascular Therapeutics Scientific Symposium |
| 26/10/2023 02:30 am | Q3 2023 Earnings Call |
| 26/10/2023 01:45 am | Q3 2023 Earnings Release |
| 25/10/2023 06:30 am | Analyst & Investor Meeting - TAVR Q&A Session at TCT |
| 07/09/2023 08:30 pm | Wells Fargo Healthcare Conference |
| 27/07/2023 02:30 am | Q2 2023 Earnings Call |
| 27/07/2023 01:45 am | Q2 2023 Earnings Release |
| 17/05/2023 | American Association for Thoracic Surgery Meeting |
| 11/05/2023 10:30 pm | Annual General Meeting |
| 07/05/2023 | American Association for Thoracic Surgery Meeting |
| 27/04/2023 02:30 am | Q1 2023 Earnings Call |
| 27/04/2023 01:45 am | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4 348 4 316 0.73% | 4 386 4 385 0.02% | 5 233 5 255 -0.43% | 5 382 5 365 0.32% | 6 005 5 972 0.55% | 6 559 |
|
EBITDA Million USD | Released Forecast Spread | 1 406 1 425 -1.36% | 1 429 1 444 -1% | 1 729 1 766 -2.07% | 1 936 1 942 -0.31% | 1 879 1 904 -1.34% | 2 080 |
|
EBIT Million USD | Released Forecast Spread | 1 316 1 328 -0.86% | 1 322 1 334 -0.9% | 1 595 1 622 -1.73% | 1 797 1 789 0.4% | 1 734 1 754 -1.15% | 1 902 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 167 1 180 -1.14% | 917 903 1.51% | 1 702 1 585 7.4% | 1 767 1 740 1.55% | 1 598 1 658 -3.62% | 1 912 |
|
Net income Million USD | Released Forecast Spread | 1 047 1 031 1.59% | 823 819 0.5% | 1 503 1 437 4.63% | 1 522 1 498 1.56% | 1 402 1 399 0.22% | 1 610 |
|
EPS USD | Released Forecast Spread | 1,64 1,63 0.61% | 1,30 1,32 -1.82% | 2,38 2,30 3.3% | 2,44 2,39 2.16% | 2,30 2,29 0.34% | 2,67 |
| Announcement Date | 30/01/20 | 27/01/21 | 26/01/22 | 31/01/23 | 06/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 330 1 354 -1.8% | 1 341 1 311 2.29% | 1 374 1 399 -1.83% | 1 319 1 333 -1.03% | 1 348 1 329 1.43% | 1 460 1 394 4.69% | 1 530 1 505 1.67% | 1 481 1 480 0.05% | 1 534 1 499 2.34% | 1 598 1 572 1.68% | 1 656 | 1 622 | 1 685 | 1 741 |
|
EBITDA Million USD | Released Forecast Spread | 398 432 -7.8% | 479 452 6.08% | 480 496 -3.14% | 493 487 1.12% | 484 481 0.7% | 469 471 -0.4% | 486 495 -1.88% | 459 458 0.08% | 465 489 -4.95% | 494 | 523 | 515 | 543 | 558 |
|
EBIT Million USD | Released Forecast Spread | 365 395 -7.49% | 445 413 7.57% | 446 460 -3.13% | 457 453 0.96% | 449 443 1.21% | 434 434 0.02% | 450 456 -1.38% | 422 419 0.64% | 428 446 -3.95% | 439 450 -2.35% | 480 | 475 | 502 | 514 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 376 325 15.78% | 436 397 9.9% | 465 435 6.79% | 407 436 -6.64% | 459 436 5.36% | 399 431 -7.62% | 339 449 -24.63% | 439 425 3.25% | 422 445 -5.24% | 409 450 -9.07% | 492 | 487 | 508 | 524 |
|
Net income Million USD | Released Forecast Spread | 335 317 5.79% | 374 343 8.94% | 406 389 4.52% | 344 383 -10.36% | 398 375 6.2% | 341 371 -8.1% | 307 375 -18.06% | 385 345 11.45% | 370 385 -3.97% | 352 379 -7.07% | 413 | 407 | 428 | 434 |
|
EPS USD | Released Forecast Spread | 0,53 0,52 2.45% | 0,59 0,56 5.36% | 0,65 0,62 5.69% | 0,55 0,61 -10.33% | 0,65 0,60 8.33% | 0,56 0,60 -7.24% | 0,50 0,61 -17.89% | 0,63 0,56 12.17% | 0,61 0,63 -3.13% | 0,58 0,63 -7.23% | 0,68 | 0,67 | 0,71 | 0,72 |
| Announcement Date | 26/01/22 | 26/04/22 | 28/07/22 | 27/10/22 | 31/01/23 | 26/04/23 | 26/07/23 | 25/10/23 | 06/02/24 | 25/04/24 | - | - | - | - |
| 29/04/2024 10:30 am | PHILIPS NV: Q1 2024 Earnings Release |
| 29/04/2024 03:30 pm | REVVITY, INC.: Q1 2024 Earnings Release |
| 30/04/2024 03:50 pm | GE HEALTHCARE TECHNOLOGIES INC.: Q1 2024 Earnings Release |
| 01/05/2024 01:35 am | TRANSMEDICS GROUP, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | INMODE LTD.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BRUKER CORPORATION: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | HOLOGIC, INC.: Q2 2024 Earnings Release |
| 03/05/2024 01:35 am | LEMAITRE VASCULAR, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | ILLUMINA, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | QUANTERIX CORPORATION: Q1 2024 Earnings Release (Projected) |
Past sector events for Edwards Lifesciences Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EW Stock
- Calendar Edwards Lifesciences Corporation
